Technology Clinical Outlooks for Regenerative Medicine, Boston. June 2012

1.Ocular ProgramsJune 20122. This presentation is intended to present a summary of ACT’s (“ACT”, or “Advanced CellTechnology Inc”, or “the Company”) salient…